Page 103 - 79_02

Long-­-life
supplementation
with
atenolol…

55.
Hybertson,
B.M.;
Gao,
B.;
Bose,
S.K.;
McCord;
J.M. Oxidative
stress
in
health
and
disease:

The
therapeutic
potential
of
Nrf2
activation.
Molecular
Aspects
of
Medicine
2011;
32,
234–
246

56.
Dogan,
S.A.;
Trifunovic,
A.
Modelling
Mitochondrial
Dysfunction
in
Mice.
Physiol.
Res.
2011;

60
(Suppl.
1),
S61-­-S70

57.
Perez-­-Campo,
R.;
López-­-Torres,
M.;
Cadenas,
S.;
Rojas,
C.;
Barja,
G.
The
rate
of
free
radical

production
as
a
determinant
of
the
rate
of
aging:
evidence
from
the
comparative
approach.

J
Comp
Physiol
B
1998;
168,
149–158

58.
Page,
M.M.;
Stuart
J.A.
Activities
of
DNA
base
excision
repair
enzymes
in
liver
and
brain

correlate
with
body
mass,
but
not
with
lifespan,
Age,
2011;
34,
1195-­-209.

59.
Barja,
G.
Free
radicals
and
aging.
Trends
in
Neurosci
2004;
27,
595-­-600

60.
Cockcroft,
J.R.;
Pedersen,
M.D.
b-­-Blockade:
Benefits
Beyond
Blood
Pressure
Reduction?
The

Journal
of
Clinical
Hypertension.
2012;
14,
112-­-120

61.
Bangalore,
S.;
Sawhney,
S.;
Messerli,
F.H.
Relation
of
beta-­-blocker-­-induced
heart
rate

lowering
and
cardioprotection
in
hypertension.
J.
Amer.
College
of
Cardiol.
2008;
52,
1482-­-
1489.

62.
Cucherat,
M.;
Borer,
J.S.
Reduction
of
Resting
Heart
Rate
With
Antianginal
Drugs:
Review

and
Meta-­-Analysis.
American
Journal
of
Therapeutics
2012;
19,
269–280

63.
London,
G.M.;
Asmar,
R.G.;
O’Rourke,
M.F.;
Safar
M.E.
Mechanism(s)
of
Selective
Systolic

Blood
Pressure
Reduction
After
a
Low-­-Dose
Combination
of
Perindopril/Indapamide
in

Hypertensive
Subjects:
Comparison
With
Atenolol.
Journal
of
the
American
College
of

Cardiology.
2004,
43,
92-­-99.

273